FNDC5 and Parkinson disease: Irisin triggers expression of brain‐derived neurotrophic factor [S31], which crosses the blood–brain barrier to enhance mitochondrial biogenesis in neurons and decrease dopaminergic loss in an animal model of PD [S32].